Regulators of skeletal development: A cluster analysis of 206 bone tumors reveals diagnostically useful markers

Modern Pathology

Volumn 25, Issue 11, 2012, Pages 1452-1461

  Horvai, Andrew E ^a   Roy, Ritu ^b   Borys, Dariusz ^c   O'Donnell, Richard J ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

bone tumor; immunohistochemistry; tissue microarray

Indexed keywords

OSTERIX; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; TUMOR MARKER; TWIST1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BONE DEVELOPMENT; BONE TUMOR; CANCER PROGNOSIS; CHONDROBLASTOMA; CHONDROMYXOID FIBROMA; GIANT CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OSTEOBLAST; OSTEOBLASTOMA; OSTEOID OSTEOMA; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY;

BONE NEOPLASMS; BONE REMODELING; CLUSTER ANALYSIS; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DIAGNOSIS, DIFFERENTIAL; HEDGEHOG PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SOX9 TRANSCRIPTION FACTOR; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TWIST TRANSCRIPTION FACTOR;

EID: 84868467012     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.110     Document Type: Article

References (47)

1. Folpe AL. MyoD1 and myogenin expression in human neoplasia: a review and update. Adv Anat Pathol 2002;9:198-203.
2. Horvai AE, Schaefer JT, Nakakura EK, et al. Immunostaining for peroxisome proliferator gamma distinguishes dedifferentiated liposarcoma from other retroperitoneal sarcomas. Mod Pathol 2008;21:517-524. (Pubitemid 351589647)
3. Ordonez NG. Application of immunocytochemistry in the diagnosis of soft tissue sarcomas: a review and update. Adv Anat Pathol 1998;5:67-85.
4. Coindre JM. Immunohistochemistry in the diagnosis of soft tissue tumours. Histopathology 2003;43:1-16. (Pubitemid 36836582)
5. Bathurst N, Sanerkin N, Watt I. Osteoclast-rich osteosarcoma. Br J Radiol 1986;59:667-673. (Pubitemid 16091078)
6. Bacchini P, Inwards C, Biscaglia R, et al. Chondroblastoma-like osteosarcoma. Orthopedics 1999;22: 337-339. (Pubitemid 29146781)
7. Schajowicz F, de Prospero JD, Cosentino E. Case report 641: chondroblastoma-like osteosarcoma. Skeletal Radiol 1990;19:603-606.
8. Nakajima H, Sim FH, Bond JR, et al. Small cell osteosarcoma of bone. Review of 72 cases. Cancer 1997; 79:2095-2106. (Pubitemid 27227373)
9. Wagner ER, Luther G, Zhu G, et al. Defective osteogenic differentiation in the development of osteosarcoma. Sarcoma 2011;2011:325238.
10. Mayordomo E, Machado I, Giner F, et al. A tissue microarray study of osteosarcoma: histopathologic and immunohistochemical validation of xenotransplanted tumors as preclinical models. Appl Immunohistochem Mol Morphol 2010;18:453-461.
11. Fanburg JC, Rosenberg AE, Weaver DL, et al. Osteocalcin and osteonectin immunoreactivity in the diagnosis of osteosarcoma. Am J Clin Pathol 1997;108: 464-473. (Pubitemid 27411299)
12. Chano T, Matsumoto K, Ishizawa M, et al. Analysis of the presence of osteocalcin, S-100 protein, and proliferating cell nuclear antigen in cells of various types of osteosarcomas. Eur J Histochem 1996;40: 189-198. (Pubitemid 27005894)
13. Lee MS, Lowe GN, Strong DD, et al. TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage. J Cell Biochem 1999;75: 566-577. (Pubitemid 29529912)
14. Jabs EW. A TWIST in the fate of human osteoblasts identifies signaling molecules involved in skull development. J Clin Invest 2001;107:1075-1077. (Pubitemid 32422902)
15. Mackie EJ, Ahmed YA, Tatarczuch L, et al. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol 2008;40:46-62. (Pubitemid 350052658)
16. Zhang C. Transcriptional regulation of bone formation by the osteoblast-specific transcription factor Osx. J Orthop Surg Res 2010;5:37.
17. He N, Xiao Z, Yin T, et al. Inducible expression of RunX2 results in multiorgan abnormalities in mice. J Cell Biochem 2011;112:653-665.
18. St-Jacques B, Hammerschmidt M, McMahon AP. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 1999;13:2072-2086. (Pubitemid 29407348)
19. Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002;108:17-29. (Pubitemid 34137009)
20. Akiyama H, Kim JE, Nakashima K, et al. Osteochondroprogenitor cells are derived from Sox9 expressing precursors. Proc Natl Acad Sci USA 2005;102:14665-14670. (Pubitemid 41457113)
21. Komori T. RunX2, a multifunctional transcription factor in skeletal development. J Cell Biochem 2002;87:1-8. (Pubitemid 34969142)
22. Huang L, Teng XY, Cheng YY, et al. Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone. Bone 2004;34:393-401. (Pubitemid 38314904)
23. Mak IW, Cowan RW, Popovic S, et al. Upregulation of MMP-13 via RunX2 in the stromal cell of Giant Cell Tumor of bone. Bone 2009;45:377-386.
24. Singh S, Mak IWY, Cowan RW, et al. The role of TWIST as a regulator in giant cell tumor of bone. J Cell Biochem 2011;112:2287-2295.
25. Dancer JY, Henry SP, Bondaruk J, et al. Expression of master regulatory genes controlling skeletal development in benign cartilage and bone forming tumors. Hum Pathol 2010;41:1788-1793.
26. Andela VB, Siddiqui F, Groman A, et al. An immunohistochemical analysis to evaluate an inverse correlation between RunX2/Cbfa1 and NF kappa B in human osteosarcoma. J Clin Pathol 2005;58:328-330. (Pubitemid 40380335)
27. Park HR, Park YK. Differential expression of RunX2 and Indian hedgehog in cartilaginous tumors. Pathol Oncol Res 2007;13:32-37.
28. Won KY, Park HR, Park YK. Prognostic implication of immunohistochemical RunX2 expression in osteosarcoma. Tumori 2009;95:311-316.
29. Fletcher CDM, Unni KK, Mertens F, (eds). Pathology and Genetics of Tumours of Soft Tissue and Bone. IARC Press: Lyon, 2002.
30. Horvai AE, Kramer MJ, Garcia JJ, et al. Distribution and prognostic significance of human telomerase reverse transcriptase (hTERT) expression in giant-cell tumor of bone. Mod Pathol 2008;21:423-430. (Pubitemid 351441030)
31. Borys D, Canter RJ, Hoch B, et al. P16 expression predicts necrotic response among osteosarcoma patients receiving neoadjuvant chemotherapy. Human Pathol; advance online publication, 9 May 2012; e-pub ahead of print; PMID:22518565.
32. Horvai AE, KramerMJ, O'Donnell R. Beta-catenin nuclear expression correlates with cyclin D1 expression in primary and metastatic synovial sarcoma: a tissue microarray study. Arch Pathol Lab Med 2006;130:792-798. (Pubitemid 43886997)
33. Adams EJ, Green JA, Clark AH, et al. Comparison of different scoring systems for immunohistochemical staining. J Clin Pathol 1999;52:75-77. (Pubitemid 29023513)
34. Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw 2010;33:1-22.
35. RDevelopmentCoreTeam. R: A Language and Environment for Statistical Computing Vol., R Foundation for Statistical Computing: Vienna, Austria, 2005.
36. Aigner T, Loos S, Inwards C, et al. Chondroblastoma is an osteoid-forming, but not cartilage-forming neoplasm. J Pathol 1999;189:463-469.
37. Wehrli BM, Huang W, De Crombrugghe B, et al. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors. Hum Pathol 2003;34:263-269. (Pubitemid 36356679)
38. Ducy P, Zhang R, Geoffroy V, et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997;89:747-754. (Pubitemid 27516177)
39. Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997; 89:755-764. (Pubitemid 27516178)
40. Otto F, Thornell AP, Crompton T, et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997;89:765-771. (Pubitemid 27516179)
41. Goldring SR, Roelke MS, Petrison KK, et al. Human giant cell tumors of bone identification and characterization of cell types. J Clin Invest 1987;79: 483-491. (Pubitemid 17009684)
42. Salerno M, Avnet S, Alberghini M, et al. Histogenetic characterization of giant cell tumor of bone. Clin Orthop Relat Res 2008;466:2081-2091.
43. Takeda S, Bonnamy JP, Owen MJ, et al. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev 2001;15:467-481. (Pubitemid 32187007)
44. Nakashima K, de Crombrugghe B. Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet 2003;19:458-466. (Pubitemid 36930029)
45. Romeo S, Oosting J, Rozeman LB, et al. The role of noncartilage-specific molecules in differentiation of cartilaginous tumors: lessons from chondroblastoma and chondromyxoid fibroma. Cancer 2007;110:385-394. (Pubitemid 47121900)
46. Romeo S, Bovee JV, Jadnanansing NA, et al. Expression of cartilage growth plate signalling molecules in chondroblastoma. J Pathol 2004;202:113-120. (Pubitemid 38072852)
47. Kindblom JM, Nilsson O, Hurme T, et al. Expression and localization of Indian hedgehog (IHH) and parathyroid hormone related protein (PTHrP) in the human growth plate during pubertal development. J Endocrinol 2002;174:R1-R6. (Pubitemid 34965776)